AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32307061 — intervention group
Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study 33253910 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic adipose‐derived mesenchymal stem cells (ASCs) injected into the lacrimal gland (LG)
Number of subjects: 7
Study 32390720 — intervention group
Group type: EXPERIMENTAL
Intervention: WB-EMS training with 20 Hz (T20)
Number of subjects: 51
Study 32390720 — intervention group
Group type: EXPERIMENTAL
Intervention: WB-EMS training with 85 Hz (T85)
Number of subjects: 51
Study 32390720 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group (CON)
Number of subjects: 51
Study 34200105 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined calcium and inulin supplementation
Number of subjects: 12
Study 34200105 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation alone
Number of subjects: 12
Study 34200105 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin supplementation alone
Number of subjects: 12
Study 33262202 — intervention group
Group type: EXPERIMENTAL
Intervention: ODM-203 400 mg/day
Number of subjects: 84
Study 35180229 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (Adapted-GMT)
Number of subjects: 12
Study 35180229 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation combined with mindfulness exercises (PSYCH-Mind)
Number of subjects: 12
Study 33739155 — intervention group
Group type: EXPERIMENTAL
Intervention: AndroForte5 (testosterone 5.0% wt/vol, 100 mg/2 mL) cream (T) + supervised center-based exercise (Ex)
Number of subjects: 80
Study 33739155 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (P) + supervised center-based exercise (Ex)
Number of subjects: 80
Study 33739155 — intervention group
Group type: EXPERIMENTAL
Intervention: AndroForte5 (T) + no additional exercise (NEx)
Number of subjects: 80
Study 33739155 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) + no additional exercise (NEx)
Number of subjects: 80
Study 33739155 — intervention group
Group type: EXPERIMENTAL
Intervention: AndroForte5 (T) + supervised center-based exercise (Ex)
Number of subjects: 80
Study 33739155 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (Ex)
Number of subjects: 80
Study 33739155 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (T)
Number of subjects: 80
Study 32853015 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Center Trauma-Sensitive Yoga (TCTSY)
Number of subjects: 64
Study 32853015 — intervention group
Group type: COMPARATOR
Intervention: Active control (women's health education)
Number of subjects: 64
Study 35300378 — intervention group
Group type: EXPERIMENTAL
Intervention: Konjaku flour (KF)
Number of subjects: 69
Study 33287758 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended chemotherapy (>6 cycles, n = 52)
Number of subjects: 135
Study 33287758 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (6 cycles, n = 83)
Number of subjects: 135
Study 33287758 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended chemotherapy (>6 cycles)
Number of subjects: 135
Study 33287758 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (6 cycles)
Number of subjects: 135
Study 32633648 — intervention group
Group type: EXPERIMENTAL
Intervention: Eggshell membrane (EM) 300 mg daily for 12 weeks
Number of subjects: 150
Study 32633648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 34963630 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression alone
Number of subjects: 85
Study 34963630 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression plus fusion
Number of subjects: 85
Study 34963630 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression plus stabilization
Number of subjects: 85
Study 34963630 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion
Number of subjects: 85
Study 34081901 — intervention group
Group type: EXPERIMENTAL
Intervention: ATF3 inhibition
Number of subjects: 0
Study 34081901 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous nucleotide supplementation
Number of subjects: 0
Study 33630649 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐EFT intervention
Number of subjects: 45
Study 33630649 — intervention group
Group type: COMPARATOR
Intervention: Vivid Memory Task (VMT) control
Number of subjects: 45
Study 33175291 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol 5/5 μg
Number of subjects: 2055
Study 33175291 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 5 μg
Number of subjects: 2055
Study 35806897 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber diet rich in polyunsaturated fatty acids (PUFAs)
Number of subjects: 0
Study 35806897 — intervention group
Group type: COMPARATOR
Intervention: Standard nutritional recommendations
Number of subjects: 0
Study 32393169 — intervention group
Group type: COMPARATOR
Intervention: Fastrach
Number of subjects: 126
Study 32393169 — intervention group
Group type: EXPERIMENTAL
Intervention: ILTS-D2
Number of subjects: 126
Study 32744215 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on, teaching kitchen culinary education class (n = 18)
Number of subjects: 41
Study 32744215 — intervention group
Group type: COMPARATOR
Intervention: Non-kitchen-based dietary counselling (n = 23)
Number of subjects: 41
Study 35220313 — intervention group
Group type: EXPERIMENTAL
Intervention: High dairy (HD) - ≥4 servings/day
Number of subjects: 24
Study 35220313 — intervention group
Group type: COMPARATOR
Intervention: Adequate dairy (AD) - ≤2 servings/day
Number of subjects: 24
Study 32103645 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (800 IU/day)
Number of subjects: 60
Study 32103645 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunlight exposure (20% to 30% of body surface areas for 30‐60 minutes per day, 3 times a week)
Number of subjects: 60
Study 32103645 — intervention group
Group type: COMPARATOR
Intervention: Daily living (control group)
Number of subjects: 60
Study 35526530 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentermine (15 mg once daily)
Number of subjects: 64
Study 35526530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 33577697 — intervention group
Group type: EXPERIMENTAL
Intervention: Rayner RAO800C IOL
Number of subjects: 68
Study 36630846 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg/day
Number of subjects: 40
Study 33820680 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy (HT)
Number of subjects: 38
Study 33820680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 38
Study 33820680 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 38
Study 33780940 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching to Increase Water Intake (CIWI)
Number of subjects: 124
Study 33780940 — intervention group
Group type: COMPARATOR
Intervention: Same water intake (control)
Number of subjects: 124
Study 35287681 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care training program in physical, psychological, social and sexual dimensions in 5 sessions during a week
Number of subjects: 70
Study 35287681 — intervention group
Group type: COMPARATOR
Intervention: Routine care and training (control group)
Number of subjects: 70
Study 32855069 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt substitution (reduced-sodium, added-potassium alternative)
Number of subjects: 0
Study 32855069 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt substitution
Number of subjects: 0
Study 32855069 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing large-scale randomised trial
Number of subjects: 0
Study 35982326 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential periosteal block (CPB)
Number of subjects: 50
Study 35982326 — intervention group
Group type: COMPARATOR
Intervention: Hematoma block (HB)
Number of subjects: 50
Study 34975078 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lignocaine medicated pad (LMP)
Number of subjects: 200
Study 34975078 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 200
Study 32342139 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening (ST) group, n=28
Number of subjects: 82
Study 32342139 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening + Balance (ST + B) group, n=28
Number of subjects: 82
Study 32342139 — intervention group
Group type: COMPARATOR
Intervention: Control group, n=26
Number of subjects: 82
Study 616914772 — intervention group
Group type: EXPERIMENTAL
Intervention: PCVC therapy (paracentesis with central venous catheter, draining 1-2 L ascites every 1 or 2 days)
Number of subjects: 112
Study 616914772 — intervention group
Group type: EXPERIMENTAL
Intervention: PCVC therapy
Number of subjects: 112
Study 616914772 — intervention group
Group type: COMPARATOR
Intervention: Control group (diuretic therapy)
Number of subjects: 112
Study 616914772 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study 33823907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm A offering HIV treatment irrespective of CD4 count
Number of subjects: 1547
Study 33823907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm B following national guidelines for universal treatment
Number of subjects: 1547
Study 35442974 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (OEP)
Number of subjects: 344
Study 35442974 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study 36121655 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 80
Study 36121655 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (control)
Number of subjects: 80
Study 33116094 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy and phototherapy
Number of subjects: 100
Study 33116094 — intervention group
Group type: COMPARATOR
Intervention: Phototherapy only
Number of subjects: 100
Study 34923602 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyft 10 mg NP
Number of subjects: 35
Study 34923602 — intervention group
Group type: EXPERIMENTAL
Intervention: Other NPs (not specified)
Number of subjects: 35
Study 34923602 — intervention group
Group type: COMPARATOR
Intervention: Cigarette
Number of subjects: 35
Study 37193566 — intervention group
Group type: EXPERIMENTAL
Intervention: LEMBOREXANT 5 mg (LEM5)
Number of subjects: 69
Study 37193566 — intervention group
Group type: EXPERIMENTAL
Intervention: LEMBOREXANT 10 mg (LEM10)
Number of subjects: 69
Study 37193566 — intervention group
Group type: COMPARATOR
Intervention: Flurazepam 30 mg
Number of subjects: 69
Study 37193566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 35311722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclined treadmill training
Number of subjects: 18
Study 32107736 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training (resistance and aerobic)
Number of subjects: 100
Study 32107736 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention following supervised exercise
Number of subjects: 100
Study 32107736 — intervention group
Group type: COMPARATOR
Intervention: Printed exercise material and recommendation to exercise
Number of subjects: 100
Study 36041991 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reflection
Number of subjects: 243
Study 36041991 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 243
Study 36041991 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 243
Study 33596356 — intervention group
Group type: EXPERIMENTAL
Intervention: Avacopan (30 mg twice daily)
Number of subjects: 331
Study 33596356 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (tapering schedule)
Number of subjects: 331
Study 32744862 — intervention group
Group type: EXPERIMENTAL
Intervention: N/A (Secondary endpoint)
Number of subjects: 10061
Study 35307223 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic stroke volume index and cardiac index in patients with LV ejection fraction <40%
Number of subjects: 303
Study 35307223 — intervention group
Group type: EXPERIMENTAL
Intervention: Low perfusion score combined with echocardiographic LV output parameters in patients with LV ejection fraction <40%
Number of subjects: 303
Study 35307223 — intervention group
Group type: EXPERIMENTAL
Intervention: Low perfusion score in patients with LV ejection fraction ≥40%
Number of subjects: 303
Study 33797199 — intervention group
Group type: EXPERIMENTAL
Intervention: IOERT (10 Gy) followed by HWBI (42.56 Gy in 16 fractions)
Number of subjects: 60
Study 33797199 — intervention group
Group type: COMPARATOR
Intervention: CWBI (50 Gy in 25 fractions) followed by EETBB (10 Gy in 5 fractions)
Number of subjects: 60
Study 33797199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IOERT+HWBI and CWBI+EETBB)
Number of subjects: 60
Study 32915900 — intervention group
Group type: COMPARATOR
Intervention: Hemosol B0 (no potassium or phosphate)
Number of subjects: 324
Study 32915900 — intervention group
Group type: COMPARATOR
Intervention: Hemosol B0 and potassium‐containing solution (MultiBic)
Number of subjects: 324
Study 32915900 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate‐ and potassium‐containing solution (Phoxilium), Hemosol B2, Prismasol 2, and Prismasol 4
Number of subjects: 324
Study 33118421 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily intake of NZBC extract (210 mg of anthocyanins, CurraNZ™) for 14 days
Number of subjects: 16
Study 33118421 — intervention group
Group type: EXPERIMENTAL
Intervention: Every-other-day intake of NZBC extract for 14 days
Number of subjects: 16
Study 33118421 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no NZBC extract)
Number of subjects: 16
Study 33077355 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-based contrast
Number of subjects: 1119
Study 33077355 — intervention group
Group type: COMPARATOR
Intervention: Water-based contrast
Number of subjects: 1119
Study 33512980 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES (neuromuscular electrical stimulation) applied to quadriceps muscles, 5 days per week for 4 weeks.
Number of subjects: 37
Study 33512980 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group).
Number of subjects: 37
Study 36178918 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation for 15 days
Number of subjects: 0
Study 36178918 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 15 days
Number of subjects: 0
Study 33517323 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐fluciclovine PET/CT (Arm B)
Number of subjects: 165
Study 33517323 — intervention group
Group type: COMPARATOR
Intervention: Conventional imaging (CI) only (Arm A)
Number of subjects: 165
Study 32819960 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual primary care for LBP and an internet intervention
Number of subjects: 0
Study 32819960 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual primary care for LBP and an internet intervention with additional physiotherapist telephone support
Number of subjects: 0
Study 32819960 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care for LBP
Number of subjects: 0
Study 35630085 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg clindamycin every 8 h for 5 days
Number of subjects: 0
Study 35630085 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg clindamycin every 8 h for 5 days
Number of subjects: 0
Study 35630085 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg clindamycin every 12 h for 5 days
Number of subjects: 0
Study 35630085 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin concentration in saliva
Number of subjects: 0
Study 34037885 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (50 mg/kg/day for 10 weeks)
Number of subjects: 30
Study 34037885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34789054 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer training (4 sets of 30 seconds sprints)
Number of subjects: 25
Study 34789054 — intervention group
Group type: COMPARATOR
Intervention: Leg press training (4 sets of 10-12 repetitions to momentary failure)
Number of subjects: 25
Study 33904913 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL-C (DSM-IV criteria)
Number of subjects: 1921
Study 33904913 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL-5 (DSM-5 criteria)
Number of subjects: 1921
Study 33904913 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL-C (for DSM-IV criteria)
Number of subjects: 1921
Study 33904913 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL-5 (for DSM-5 criteria)
Number of subjects: 1921
Study 33904913 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL-C and PCL-5
Number of subjects: 1921
Study 32918853 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet-VOO (n = 120)
Number of subjects: 358
Study 32918853 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet-Nuts (n = 119)
Number of subjects: 358
Study 32918853 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet adherence increments
Number of subjects: 358
Study 32918853 — intervention group
Group type: COMPARATOR
Intervention: Control diet (n = 119)
Number of subjects: 358
Study 34449355 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcutaneous cervical vagus nerve stimulation (tcVNS)
Number of subjects: 50
Study 34449355 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous cervical vagus nerve stimulation (tcVNS)
Number of subjects: 50
Study 34844625 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy plus home stretching exercises
Number of subjects: 131
Study 34844625 — intervention group
Group type: COMPARATOR
Intervention: Home stretching exercises alone
Number of subjects: 131
Study 34923903 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Prob) + Berberine (BBR)
Number of subjects: 365
Study 34923903 — intervention group
Group type: COMPARATOR
Intervention: Berberine (BBR) alone
Number of subjects: 365
Study 34923903 — intervention group
Group type: COMPARATOR
Intervention: Probiotics (Prob) alone
Number of subjects: 365
Study 32540779 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-flap Z-frenuloplasty
Number of subjects: 37
Study 32540779 — intervention group
Group type: COMPARATOR
Intervention: simple frenotomy
Number of subjects: 37
Study 34047410 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional deep brain stimulation (DBS)
Number of subjects: 234
Study 34047410 — intervention group
Group type: COMPARATOR
Intervention: Omnidirectional deep brain stimulation (DBS)
Number of subjects: 234
Study 33346587 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher concentrations of Lactobacillus crispatus
Number of subjects: 84
Study 33346587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 34369667 — intervention group
Group type: COMPARATOR
Intervention: PF-06730512 (up to 1000 mg IV single ascending dose)
Number of subjects: 79
Study 34369667 — intervention group
Group type: COMPARATOR
Intervention: PF-06730512 (up to 400 mg SC multiple ascending doses)
Number of subjects: 79
Study 34369667 — intervention group
Group type: COMPARATOR
Intervention: PF-06730512 (up to 1000 mg IV multiple ascending doses)
Number of subjects: 79
Study 34369667 — intervention group
Group type: COMPARATOR
Intervention: Placebo (IV and SC)
Number of subjects: 79
Study 34001230 — intervention group
Group type: EXPERIMENTAL
Intervention: Food for Mind (FM) nutrition intervention
Number of subjects: 144
Study 34001230 — intervention group
Group type: COMPARATOR
Intervention: Bring Good Mood (BGM) social support control group
Number of subjects: 144
Study 32521324 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led program of systematic screening for comorbidities
Number of subjects: 502
Study 35533322 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure for 3 minutes every day for 5 days
Number of subjects: 60
Study 35533322 — intervention group
Group type: COMPARATOR
Intervention: Classical abdominal massage for 15‐20 minutes every day for 5 days
Number of subjects: 60
Study 36151279 — intervention group
Group type: EXPERIMENTAL
Intervention: Revitalisation technique
Number of subjects: 20
Study 36151279 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)-based technique
Number of subjects: 20
Study 33486783 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy (ET)
Number of subjects: 1343
Study 33486783 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy (ET)
Number of subjects: 1343
Study 33726735 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental patient benefit
Number of subjects: 606
Study 33726735 — intervention group
Group type: COMPARATOR
Intervention: Incremental cost-effectiveness ratio (ICER)
Number of subjects: 606
Study 33726735 — intervention group
Group type: COMPARATOR
Intervention: Price magnitude framing
Number of subjects: 606
Study 33726735 — intervention group
Group type: EXPERIMENTAL
Intervention: Relevance of patient
Number of subjects: 606
Study 32873443 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology massage (20 min for 3 days, 15 min before changing wound dressings)
Number of subjects: 52
Study 32873443 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 52
Study 34543419 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative weekly change of progression >10% in running volume and progression in running pace
Number of subjects: 586
Study 34543419 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute weekly change of progression >5 km in running volume and progression in running pace
Number of subjects: 586
Study 34671676 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral synthetic vitamin E (400 IU/day) for eight weeks
Number of subjects: 124
Study 34671676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 33874898 — intervention group
Group type: COMPARATOR
Intervention: IV normal saline (Group C)
Number of subjects: 45
Study 33874898 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg IV aminophylline (Group A1)
Number of subjects: 45
Study 33874898 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/kg IV aminophylline (Group A2)
Number of subjects: 45
Study 32091536 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 4044
Study 32091536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4044